Saturday, 17 August 2019

International Society of Cell Therapy appoints Dr Anish Majumdar as VP-Elect for Asia

20 March 2015 | Influencers | By BioSpectrum Bureau

International Society of Cell Therapy appoints Dr Anish Majumdar as VP-Elect for Asia

Dr Anish S Majumdar, chief scientific officer and executive VP, Stempeutics Research

Dr Anish S Majumdar, chief scientific officer and executive VP, Stempeutics Research

Singapore: Dr Anish S Majumdar, chief scientific officer and Executive VP at India based Stempeutics Research, is elected as the vice president-elect of Asia region of International Society of Cell Therapy to represent India and Asia.

Dr Majumdar has been with Stempeutics Research since 2010 and has been leading the R&D for mesenchymal stem cell research and therapy. The internationally known stem cell researcher also has been working since 20-25 years towards elucidating the potential of various stem cells and their applications for incurable diseases at Indian and USA organizations. Being nominated a member of the industry committee of the International Stem Cell Research and Therapy, Dr Anish also delivered more than hundred lectures on various aspects of his research at various National and International conferences.

"Stem cell research and therapy will eventually reshape the healthcare industry and I am honored to be a part of the International Society of cell Therapy to be representing India as well as Asia at an international level. At Stempeutics Research, we have the opportunity to deliver breakthrough solutions which will bring value to our investors, clients and stakeholders." said Dr  Majumdar.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls